Bill > S5040

This bill aims to regulate certain communications regarding prescription drugs, particularly those made by social media influencers and healthcare providers. It imposes civil penalties for false or misleading communications about prescription drugs, including those that omit required safety and effectiveness information. The bill also requires disclosure of payments made by drug manufacturers or healthcare providers to social media influencers for promoting or communicating about drugs. Additionally, it authorizes the Secretary of Health and Human Services to conduct market surveillance activities to monitor prescription drug advertising and promotion on social media platforms, and to provide notice to drug manufacturers of potentially non-compliant communications by healthcare providers or influencers.